Search Results 891-900 of 38844 for Liver failure

  1. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Terry M. Therneau, Ph.D. - Mayo Clinic Faculty Profiles

    Terry M. Therneau, Ph.D., is a Mayo Clinic statistician focused on aging and dementia, Alzheimer's disease, liver disease, and survival analysis.

  3. Mayo Clinic graduate students tackle diabetes and liver disease

    Since type 2 diabetes and non-alcoholic fatty liver disease are associated with metabolism, understanding the mechanisms that drive these cellular cargo trucks ...

  4. Alina M. Allen, M.D., M.S. - Mayo Clinic Faculty Profiles

    The research program of Alina M. Allen, M.D., at Mayo Clinic is focused on improving outcomes for patients with nonalcoholic fatty liver disease (NAFLD).

  5. Exploring the use of MRE and liver stiffness measurement to guide treatment and predict outcomes in patients with NAFLD - Mayo Clinic

    The ability to monitor disease progression in nonalcoholic fatty liver disease (NAFLD) and understand its impact on liver outcomes remains poorly understood ...

  6. A Study Of VR To Improve Tolerability During Paracentesis And Liver Biopsies - Mayo Clinic

    ... disease, heart arrhythmia. ... The purpose of this study is to assess the effectiveness of VR during paracentesis and liver ... disease, and previous treatments or ...

  7. Cirrhosis - Doctors and departments - Mayo Clinic

    This advanced stage of liver damage ... Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis.

  8. Foam Sclerotherapy for the Treatment of Symptomatic Kidney or Liver Cysts in Patients with Autosomal Dominant Polycystic Kidney and Liver Disease - Mayo Clinic

    ... disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD). Participation eligibility. Participant eligibility includes age, gender, type and ...

  9. Trimethobenzamide (oral route) - Side effects & dosage - Mayo Clinic

    Kidney disease—Use with caution. The effects of this medicine may be increased because of slower removal from the body. Liver disease—Use with caution. May ...

  10. A Study of Dapagliflozin in the Failing Fontan Circulation - Mayo Clinic

    Severe kidney disease (estimated GFR\<30) or liver disease 10. Women of childbearing potential not willing to use a medically accepted method of ...